Isabelle de Zegher
Directeur/Membre du Conseil chez International Health Terminology Standards Development
Profil
Isabelle de Zegher currently works as a Director at Clinical Data Interchange Standards Consortium, Inc. She is currently working as a Director at International Health Terminology Standards Development.
Postes actifs de Isabelle de Zegher
| Sociétés | Poste | Début |
|---|---|---|
International Health Terminology Standards Development
 International Health Terminology Standards Development Miscellaneous Commercial ServicesCommercial Services International Health Terminology Standards Development improves healthcare by setting standards for a codified language that represents clinical terms. The non-profit company is based in London, UK. This enables healthcare information to be exchanged efficiently for the benefit of patients and other stakeholders. Snomed International, a not-for-profit organization, owns and develops Snomed CT, the world's most comprehensive healthcare terminology product. The CEO of the British company is Don Sweete. | Directeur/Membre du Conseil | 07/10/2020 |
Clinical Data Interchange Standards Consortium, Inc.
 Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
International Health Terminology Standards Development
International Health Terminology Standards Development Miscellaneous Commercial ServicesCommercial Services International Health Terminology Standards Development improves healthcare by setting standards for a codified language that represents clinical terms. The non-profit company is based in London, UK. This enables healthcare information to be exchanged efficiently for the benefit of patients and other stakeholders. Snomed International, a not-for-profit organization, owns and develops Snomed CT, the world's most comprehensive healthcare terminology product. The CEO of the British company is Don Sweete. | Commercial Services |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | Commercial Services |
